Scientists breed special rats to learn more about hypertension

September 22, 2005

WINSTON-SALEM, N.C. - Scientists at Wake Forest University School of Medicine have created a better research rat - the first to enable them to study how declining estrogen after menopause can affect hypertension, heart failure and kidney damage.

"By changing a single gene that is involved in hypertension, varying effects were revealed that we never expected," said Mark Chappell, Ph.D., senior researcher in the Hypertension and Vascular Disease Center. "These rats will allow us to study salt-sensitivity in hypertension as well as explore how estrogen depletion affects several body systems. And this is just the tip of the iceberg. We're just starting to discover what this animal model can teach us."

Chappell and colleagues are presenting three reports on their research this week at the American Heart Association's 59th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research in association with the Council on the Kidney in Cardiovascular Disease. The meeting is in Washington, D.C.

"These projects suggest that estrogen may be protective, not only in renal function and development of hypertension, but in heart function," said Chappell. "Next, we will look at different therapies, including different formulations of estrogen that may lack some of the deleterious effects associated with estrogen therapy."

In a study led by Leanne Groban, M.D., an associate professor of cardiac anesthesia, the team looked at how estrogen depletion affects diastolic dysfunction. In this common form of heart failure, the heart muscle becomes stiff and cannot fill with enough blood to meet the body's demands. Diastolic dysfunction is more common in women after menopause and is frequently associated with hypertension.

In these rats, the researchers found that estrogen depletion exacerbates the progression of diastolic dysfunction. Scientists have long known that estrogen helps protect heart vessels from atherosclerosis, the buildup of fatty deposits that can cause heart attacks. This research suggests that it may also protect heart function.

"Estrogen seems to exert protective actions on heart performance that may be independent from any changes in blood pressure," said Groban.

Chappell led a project to determine if estrogen is also protective against the hypertension and renal damage that arises from excess salt in the diet. In the rats fed a high salt diet, estrogen depletion increased blood pressure and exacerbated renal injury. The lack of estrogen resulted in increase levels of a hormone called aldosterone that may contribute to both diastolic dysfunction and kidney injury.

"This seems to go hand in hand with studies published recently showing that blocking aldosterone is protective to the heart and kidneys irrespective of its effects on blood pressure," said Chappell, an associate professor in the School of Medicine, which is part of Wake Forest University Baptist Medical Center.

In the third project, the scientists found that estrogen depletion results in marked increases in blood pressure, which they hope will help them understand why a woman's chances of getting high blood pressure increase considerably after menopause. Led by Liliya Yamaleyeva, M.D., the researchers measured nitric oxide, a hormone that has been found to relax blood vessels and lower blood pressure.

Three different enzymes are involved in nitric oxide formation and the researchers found that estrogen depletion augments one of the enzymes, but markedly reduces one of the others.

"We conclude that one of the nitric oxide enzymes may be an important mechanism that causes blood pressure to increase after estrogen depletion," said Yamaleyeva.

The development of an animal that is sensitive to estrogen's effects is significant because most human and animal hypertension research has focused on males. The rats are also sensitive to salt, which will help the researchers work to learn more about how salt intake affects blood pressure in both men and women.

"We'll see if there are differences between males and females in how they respond to treatments and whether they are salt-sensitive," said Chappell. "About half of people with hypertension have increased pressure when they consume high levels of salt and we don't know why."

This research is funded by National Heart, Lung, and Blood Institute and the American Heart Association. The new strain of so-called "designer" rats are created by transferring one or several specific genes of interest to a recipient rat and allows scientists to better learn how genes may work together to cause cardiovascular disease in humans.
Media Contacts: Karen Richardson,; Ann Hopkins,, at 336-716-4587.

About Wake Forest University Baptist Medical Center: Wake Forest Baptist is an academic health system comprised of North Carolina Baptist Hospital and Wake Forest University Health Sciences, which operates the university's School of Medicine. The system comprises 1,187 acute care, psychiatric, rehabilitation and long-term care beds and is consistently ranked as one of "America's Best Hospitals" by U.S. News & World Report.

Wake Forest Baptist Medical Center

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to